Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 6 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 6

From: "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)

Fig. 6

A 69-year-old female cardiac and diabetic patient who had received “Sinopharm” vaccine then got COVID-19 infection. A, B Axial chest CT cuts (lung window) showed bilateral mainly peripheral located and to lesser extent bronchocentric ground-glass pneumonic patches. C CT-Volumetry of the pathological lung parts averages 1053 cc. D CT-Volumetry of total lung volume averages 2204 cc. So, 48% of the lung parenchyma was diseased (Score 2)

Back to article page